XOMA Co. (NASDAQ:XOMAP – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 308 shares, an increase of 152.5% from the April 30th total of 122 shares. Based on an average daily volume of 771 shares, the short-interest ratio is presently 0.4 days.
XOMA Stock Up 0.1%
NASDAQ:XOMAP opened at $25.45 on Friday. The company has a 50-day moving average price of $25.84 and a 200-day moving average price of $26.18. XOMA has a 12 month low of $25.14 and a 12 month high of $30.00.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Read More
- Five stocks we like better than XOMA
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
